4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001415889-25-008709
GENERAL COUNSEL & CORP SEC sold 4,211 shares at an average $8.49 ($35,731)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-03-18 | Sale | −2,266 | $8.67 | $19,646 | 33,510 | D |
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-03-19 | Sale | −1,945 | $8.27 | $16,085 | 31,565 | D |
| Derivatives | |||||||
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-03-20 | Grant or award · Employee Stock Option (Right to Buy) | +72,000 | 72,000 | D | ||
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-03-20 | Grant or award · Restricted Stock Units | +48,000 | 48,000 | D | ||
| Open-market sales · 4,211 sh · avg $8.49 · $35,731 | |||||||
Loading xslF345X05/form4-03202025_100334.xml…